Jonathan has 30 years of worldwide regulatory and clinical affairs experience across medical devices, combination products and human/veterinary pharmaceuticals.
Following completion of his PhD in veterinary pathophysiology, Jonathan began his career in regulatory affairs at A H Robins. He subsequently held regulatory affairs positions in drug and device companies, including Smith & Nephew, Glaxo and Bristol-Myers Squibb. Jonathan has served on two European Commission Expert Working Groups on the Drug/Device Borderline and Device Classification. After 20 years with ConvaTec, most recently as Vice President of Global Regulatory & Clinical Affairs, Jonathan now runs his own consulting firm, JHRA, specialising in medical device and combination product regulatory affairs.
Jonathan has been an active member of TOPRA since 1987; he is a Fellow and member of the Med Tech SPIN group and has been a regular contributor on numerous educational and training programmes, delivering Introductory Course lectures and acting as Module Advisor/lecturer for two of the TOPRA UH M.Sc. course modules.